Zentalis Pharmaceuticals, Inc. — 10-Q Filings
18 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Zentalis Pharmaceuticals, Inc. (ZNTL), sorted by most recent first. Each row links to the full filing on EdgarLookup. Zentalis Pharmaceuticals, Inc. has filed 18 10-Q documents with the SEC since 2017. To view all SEC filings by Zentalis Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001725160-25-000161 | Nov 10, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001725160-25-000149 | Aug 6, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001725160-25-000105 | May 14, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0001725160-24-000173 | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0001725160-24-000158 | Aug 9, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0001725160-24-000107 | May 7, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0001725160-23-000196 | Nov 6, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0001725160-23-000155 | Aug 9, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0001725160-23-000113 | May 10, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0001725160-22-000200 | Nov 9, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001725160-22-000155 | Aug 9, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001725160-22-000093 | May 5, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001725160-21-000220 | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001725160-21-000183 | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001725160-21-000129 | May 17, 2021 | Mar 31, 2021 |
| 10-Q | 10-Q | 0001725160-20-000034 | Nov 9, 2020 | Sep 30, 2020 |
| 10-Q | 10-Q | 0001725160-20-000016 | Aug 13, 2020 | Jun 30, 2020 |
| 10-Q | 10-Q | 0001725160-20-000007 | May 15, 2020 | Mar 31, 2020 |